Nathwani Nitya - Dept Hematol & Hematopoiet Stem Cell Transplantat, City Hope Natl Med Ctr

基本信息

浏览量：50

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 80 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

An Open-Label, First-in-human, Single Agent, Dose Escalation Study for the Evaluation of Safety and Efficacy of SAR442085 in Patients with Relapsed or Refractory Multiple Myeloma

Prashant Kapoor,Nitya Nathwani,Tomas Jelinek,Ludek Pour, Aurore Perrot,Meletios-Athanasios Dimopoulos,Shang-Yi Huang,Ivan Spicka,Saurabh Chhabra,Eben Lichtman,Maria-Victoria Mateos,Dheepak Kanagavel, Liang Zhao,Helene Guillemin-Paveau,Sandrine Mace,Helgi van de Velde,Paul G. Richardson

EUROPEAN JOURNAL OF HAEMATOLOGY（2024）

引用0浏览0WOS引用

P-392 A Phase 1 Trial of 225Actinium-Dotadaratumumab in Patients with Daratumumab-Refractory Multiple Myeloma: Results from First Cohorts

Scott Goldsmith,Vikram Adhikarla,Murali Janakiram,Michael Rosenzweig,Savita Dandapani,Nitya Nathwani,Azra Borogovac, Sarah Lee,Arnab Chowdhury,Jonathan Keats,James Sanchez,Erasmus Poku,Russell Rockne,Paul Yazaki,Jeffrey Wong, John E. Shively,Flavia Pichiorri,Amrita Krishnan

Clinical Lymphoma Myeloma and Leukemia (2024): S260

引用0浏览0引用

Opportunity Cost of Oncology Subspecialist Opinion

Afsaneh Barzi, Crystal Liang, Carol Wright,Nitya Nathwani, Debra A. Wong, Todd M. Sachs

Journal of Clinical Oncologyno. 16_suppl (2024): e13578-e13578

引用0浏览0引用

OA-58 Sonrotoclax Plus Dexamethasone Was Tolerable and Demonstrated Antimyeloma Activity in Patients with Relapsed/Refractory Multiple Myeloma Harboring T(11; 14)

Abel Costa,Binod Dhakal,Malin Hultcrantz, Susan Bal, Hun Chuah,Jonathan L. Kaufman,Dickran Kazandjian,Nitya Nathwani, Gordon Royle,Douglas W. Sborov, Christopher P. Venner, Huan Cheng, Adam Idoine, Amit Agarwal,Hang Quach

Clinical Lymphoma Myeloma and Leukemia (2024): S36-S37

引用0浏览0引用

P-031 Phase I Study to Evaluate Cellular Immunotherapy Using CS-1 Targeting Autologous CAR T Cells in Patients with Relapsed and Refractory Multiple Myeloma (RRMM)

Myo Htut,Michael Rosenzweig,Amrita Krishnan,Nitya Nathwani,Scott Goldsmith,Murali Janakiram, Sarah Lee,Azra Borogovac, Adria Arencibia,Jinny Paul,Min Guan,Vibhuti Vyas,Dileshni Tilakawardane,Jamie Wagner,Arnab Chowdhury,Elizabeth Budde, Stephen Forman,Xiuli Wang

Clinical Lymphoma Myeloma and Leukemia (2024): S58-S59

引用0浏览0引用

A Multi-Center, Phase Ib Study of Subcutaneous Administration of Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma

Hang Quach,Gurdeep Parmar, Enrique M Ocio,H Miles Prince,Albert Oriol, Helen Crowther,Nobuhiro Tsukada,Pierre Bories,Sumit Madan,Nitya Nathwani,Kazutaka Sunami,Dorothee Semiond,Disa Yu, Paul Cordero,Sandrine Macé,Florence Suzan,Philippe Moreau

Haematologicapp.0-0, (2024)

引用0浏览0WOS引用

Selinexor, Ixazomib, Pomalidomide and Dexamethasone in Functionally High-Risk Multiple Myeloma: Results from the Myeloma Developing Regimens Using Genomics (mydrug) Sub-Protocol Y3

Joshua Richter,Jeffrey A. Zonder,Nitya Nathwani,Giada Bianchi,Craig C. Hofmeister,Ravi Vij,Matthew Pianko,Gurbakhash Kaur,Malin Hultcrantz, Katie Wozniak, Mercedes Martillo,Hearn Jay Cho,Shaji Kunnathu Kumar

Blood（2023）

引用0浏览0引用

A phase 2 trial of leflunomide, pomalidomide, and dexamethasone for relapsed/refractory multiple myeloma

Michael Rosenzweig,James Sanchez,Arnab Chowdhury,Nitya Nathwani,Murali Janakiram,Myo Htut,Firoozeh Sahebi, Tricia Walker,Flavia Pichiorri,Joycelynne Palmer,Amrita Krishnan,Jonathan Keats,Steven Rosen

Clinical Lymphoma Myeloma and Leukemia (2023): S153-S153

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn